Exdensur is now the first twice-yearly add-on maintenance therapy approved for use in severe eosinophilic asthma.
Nona Biosciences ("Nona"), a global biotechnology company providing integrated solutions for biological drug discovery and development from "Idea to IND" (I to I®), and Valink Therapeutics ("Valink"), ...
Investor's Business Daily on MSN
OpenAI gears up for bigger AI battles, IPO buzz in 2026
Artificial intelligence pioneer OpenAI in 2026 will aim to maintain AI model leadership, push into enterprise apps, and ...
Upstate Ramblings on MSN
Easy no-bake red velvet cheesecake with gorgeous swirls
The post Easy No-Bake Red Velvet Cheesecake With Gorgeous Swirls appeared first on Upstate Ramblings.
The undefeated Blue Devils have two more non-conference games on the schedule. One seems like a given for the college ...
Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results